Lipocine Inc.LPCNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank71
5Y CAGR-2.5%
Studio
Year-over-Year Change

Research and development spending

5Y CAGR
-2.5%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$8.58M+16.8%
2024$7.35M-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$9.75M+30.5%
2019$7.47M+15.5%
2018$6.46M-41.3%
2017$11.00M+36.3%
2016$8.08M-